Bishal Gyawali: I Hope Trial Sponsors and Trialists Will Find These Results Helpful and Meaningful
Bishal Gyawali, Associate Professor at Queen’s University, shared on X about a recent paper shared by Luís Felipe Leite et al. published in BMJ Oncology:
“Brand new paper just live in BMJ Oncology. In this study, we evaluate if DFS can be a reliable surrogate for OS in early-stage pancreatic cancer trials. I hope trial sponsors and trialists will find these results helpful and meaningful. Link in next comment.
Special shout out to my mentee from Brazil, the first author of this paper, Luís Felipe Leite who led this project and worked really hard to bring this to completion.”
Title: Disease-free survival as a surrogate for overall survival in early-stage pancreatic cancer trials: a correlation meta-analysis
Authors: Luís Felipe Leite, Luiz F. Costa de Almeida, Lucas Diniz da Conceição, Mariana Macambira Noronha, Marcos Belotto, Erick F. Saldanha, Thais Baccili Cury Megid, Renata D’Alpino Peixoto, Bishal Gyawali
More posts featuring Bishal Gyawali.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023